NCT05426213撤回不适用
A Real-World Study to Evaluate the Effectiveness and Safety of Robot-Assisted Bronchoscopy in Chinese Patients With Lung Lesions
适应症
干预措施
试验速览
- 阶段
- 不适用
- 状态
- 撤回
- 主要终点
- Navigation Success Rate
研究概览
简要总结
Robot-assisted bronchoscopy biopsy procedure will be conducted for all eligible subjects under general anesthesia status by trained investigators in hospital.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Diagnostic
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 80 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Capable and willing to give informed consent
- •Acceptable candidate for an elective, non-emergency bronchoscopic procedure
- •Lung lesions suspected of malignancy, between 8-50 millimeters (mm) in diameter size identified on thin slice (0.9-1.25 mm) computed tomography (CT) scan within 14 days, requiring bronchoscopic biopsy for diagnosis
- •No more than 1 lung lesion will be targeted for robot-assisted bronchoscopy biopsy
排除标准
- •Pre-Operative
- •Participants with pure ground-glass opacity lesions on pre-procedure chest CT
- •Participants with the target lesion having endobronchial involvement seen on chest CT
- •Medical contraindications to bronchoscopy and/or anesthesia as assessed by the investigator (such as severe cardiac arrhythmias, severe hypertension, severe cardiopulmonary dysfunction, myocardial infarction, unstable angina pectoris et cetera [etc]) precluding safe bronchoscopic procedure
研究组 & 干预措施
Robot-assisted Bronchoscopy
Other
Participants with 8-50 millimeters (mm) diameter size lung lesions identified on computed tomography (CT) scan will be enrolled for robotic assisted bronchoscopy (Monarch Platform) biopsy procedure.
干预措施: Robot-assisted Bronchoscopy (Monarch Platform) (Device)
结局指标
主要结局
Navigation Success Rate
时间窗: Intraoperative
Navigation success rate is defined as the percentage of successful navigation to the targeted lung lesion (lesion localization) as confirmed by radial probe endobronchial ultrasound (R-EBUS) imaging through Monarch Platform during bronchoscopy procedure.
次要结局
- Total Procedure Time(Intraoperative)
- Number of Conversion to Conventional Bronchoscopic Procedure(Intraoperative)
- Time to R-EBUS Confirmation(Intraoperative)
- Time to the Tissue Acquisition(Intraoperative)
- Number of Participants with Pneumothorax Requiring Intervention(Up to 7 days post procedure)
- Number of Participants with Device or Procedure Related Respiratory Failure(Up to 7 days post procedure)
- Number of Participants with Device or Procedure Related Bleeding Requiring Medical Intervention(Up to 7 days post procedure)
研究者
相似试验
尚未招募
不适用
Adequacy Assessment of Bronchoscopic Biopsy Samples Using a Novel InstrumentLung DiseasesLung CancerNCT06499454Ruby Robotics Inc50
已完成
不适用
Robotic Versus Electromagnetic Bronchoscopy for Pulmonary LesIon AssessmeNT: (the RELIANT Trial)Peripheral Pulmonary LesionsNCT05705544Vanderbilt University Medical Center447
尚未招募
不适用
Sd-RAB for the Diagnosis of PPNsPeripheral Pulmonary NodulesNCT06719687Shanghai Chest Hospital30
已完成
2 期
A Study to Test Whether Different Doses of BI 1291583 Help People With BronchiectasisBronchiectasisNCT05238675Boehringer Ingelheim322
招募中
不适用
ENB-guided Ablation Therapy Combined With VATS in the Treatment of MPLCLung CancerNCT04730453Shanghai Chest Hospital30